Cencora Inc (COR)

$337.63 +2.32 (0.69%)
Market Cap 67.99B
Revenue (ttm) 321.33B
Net Income (ttm) 1.55B
EPS (ttm) N/A
PE Ratio 21.93
Forward PE 19.85
Profit Margin 0.48%
Debt to Equity Ratio 4.38
Volume 1,283,055
Avg Vol 1,433,752
Day's Range N/A - N/A
Shares Out 193.88M
Stochastic %K 10%
Beta 0.63
Analysts Strong Sell
Price Target $391.93

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
AtomicAIerts
AtomicAIerts Dec. 5 at 5:45 AM
$COR AtomicAlerts Scalp Alert Direction: SHORT Entry: $337.65 TP1: $336.95 | TP2: $336.25 | TP3: $335.55 Stop Loss: $338.25 👉 https://atomicalerts.com
0 · Reply
Iightning
Iightning Dec. 5 at 1:07 AM
1ightning® Premium Options Alert (Actionable) Ticker: $COR Contract: Dec 19 $340C Entry: 6.75 Exit: 13.20 Return: +95.57% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 7:36 PM
1ightning® Premium Options Alert (Actionable) Ticker: $COR Contract: Dec 19 $340C Entry: 6.75 Exit: 13.20 Return: +95.57% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 4:12 PM
$COR AtomicAlerts® Scalp Alert Direction: SHORT Entry: $335.73 TP1: $335.03 | TP2: $334.33 | TP3: $333.63 Stop Loss: $336.33 EMA9: 335.65 | EMA21: 335.72 RSI14: 40.22 | VWAP: 338.52 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 2:36 PM
$COR AtomicAlerts® Scalp Alert Direction: SHORT Entry: $335.45 TP1: $334.75 | TP2: $334.05 | TP3: $333.35 Stop Loss: $336.05 EMA9: 335.1 | EMA21: 334.85 RSI14: 64.78 | VWAP: 338.69 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 1:01 PM
$COR AtomicAlerts® Scalp Alert Direction: SHORT Entry: $335.28 TP1: $334.58 | TP2: $333.88 | TP3: $333.18 Stop Loss: $335.88 EMA9: 334.65 | EMA21: 334.57 RSI14: 58.63 | VWAP: 344.31 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 11:27 AM
$COR AtomicAlerts® Scalp Alert Direction: SHORT Entry: $335.28 TP1: $334.58 | TP2: $333.88 | TP3: $333.18 Stop Loss: $335.88 EMA9: 334.65 | EMA21: 334.57 RSI14: 58.63 | VWAP: 344.31 Paid Alerts: https://atomicalerts.com
0 · Reply
Iightning
Iightning Dec. 4 at 3:20 AM
1ightning® Premium Options Alert (Actionable) Ticker: $COR Contract: Dec 19 $340C Entry: 5.95 Exit: 11.36 Return: +90.89% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Arcides
Arcides Dec. 3 at 7:09 PM
$COR $MCK both had follow through down today...for now looks like ride is over.
3 · Reply
Knowledgeworthmore
Knowledgeworthmore Dec. 3 at 8:17 AM
$OTLK dont forget that yesterday he mention that, $COR was very fast to open global market for otlk for new comers cor is partner eith otlk for global market.
0 · Reply
Latest News on COR
Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

Dec 3, 2025, 7:30 AM EST - 1 day ago

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 3:33 PM EST - 2 days ago

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 2, 2025, 12:53 PM EST - 2 days ago

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cencora: Earnings Visibility Driving Re-Rating Potential

Nov 7, 2025, 2:05 PM EST - 27 days ago

Cencora: Earnings Visibility Driving Re-Rating Potential

Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript

Nov 5, 2025, 4:01 PM EST - 4 weeks ago

Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript

Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast

Nov 5, 2025, 7:44 AM EST - 4 weeks ago

Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

Nov 5, 2025, 7:00 AM EST - 4 weeks ago

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

Nov 5, 2025, 7:00 AM EST - 4 weeks ago

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Nov 5, 2025, 6:30 AM EST - 4 weeks ago

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November

Nov 1, 2025, 11:15 PM EDT - 4 weeks ago

ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November

ABBV ADP AEP AIZ AOS ATO BDX

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

Oct 16, 2025, 9:00 AM EDT - 7 weeks ago

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Oct 14, 2025, 12:47 PM EDT - 7 weeks ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

MCK WFC

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

Oct 6, 2025, 4:30 PM EDT - 2 months ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 2:05 PM EDT - 3 months ago

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 6:02 PM EDT - 3 months ago

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 5, 2025, 11:11 AM EDT - 3 months ago

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Aug 27, 2025, 4:15 PM EDT - 3 months ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Aug 12, 2025, 2:31 PM EDT - 4 months ago

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Aug 8, 2025, 5:08 PM EDT - 4 months ago

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Aug 6, 2025, 12:25 PM EDT - 4 months ago

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Cencora raises annual profit forecast on strong demand for specialty drugs

Aug 6, 2025, 7:51 AM EDT - 4 months ago

Cencora raises annual profit forecast on strong demand for specialty drugs

Cencora Reports Fiscal 2025 Third Quarter Results

Aug 6, 2025, 6:30 AM EDT - 4 months ago

Cencora Reports Fiscal 2025 Third Quarter Results

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Jul 3, 2025, 7:30 AM EDT - 5 months ago

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 6 months ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

May 16, 2025, 8:37 AM EDT - 7 months ago

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

May 7, 2025, 2:06 PM EDT - 7 months ago

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

May 7, 2025, 10:55 AM EDT - 7 months ago

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 7 months ago

Cencora Reports Fiscal 2025 Second Quarter Results

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 8 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM

These 15 stocks are the most profitable companies in the S&P 500

Mar 31, 2025, 7:35 AM EDT - 8 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX DVA

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Mar 28, 2025, 7:00 AM EDT - 9 months ago

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Feb 26, 2025, 11:00 AM EST - 10 months ago

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Feb 6, 2025, 8:37 PM EST - 10 months ago

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

Feb 6, 2025, 8:30 PM EST - 10 months ago

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

WBA

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Feb 6, 2025, 8:30 AM EST - 10 months ago

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Cencora (COR) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 11:40 AM EST - 10 months ago

Cencora (COR) Q1 2025 Earnings Call Transcript

Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 10 months ago

Cencora raises 2025 profit forecast on specialty drug demand

Cencora Reports Fiscal 2025 First Quarter Results

Feb 5, 2025, 6:30 AM EST - 10 months ago

Cencora Reports Fiscal 2025 First Quarter Results

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

Jan 27, 2025, 7:30 AM EST - 11 months ago

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

HROW

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

Jan 13, 2025, 12:07 PM EST - 11 months ago

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

COST DHR EL MSGS WST

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Jan 8, 2025, 7:30 AM EST - 11 months ago

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Cencora raises annual profit forecast

Jan 2, 2025, 4:23 PM EST - 1 year ago

Cencora raises annual profit forecast

Cencora Completes Acquisition of Retina Consultants of America

Jan 2, 2025, 4:15 PM EST - 1 year ago

Cencora Completes Acquisition of Retina Consultants of America

Cencora Closes $1.8 Billion Senior Notes Offering

Dec 9, 2024, 4:15 PM EST - 1 year ago

Cencora Closes $1.8 Billion Senior Notes Offering

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

Dec 6, 2024, 8:30 AM EST - 1 year ago

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

Cencora: Competitive Advantages Defined

Dec 5, 2024, 10:26 AM EST - 1 year ago

Cencora: Competitive Advantages Defined

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

Dec 2, 2024, 10:49 PM EST - 1 year ago

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

Cencora to Host Inaugural Product Showcase

Nov 26, 2024, 8:30 AM EST - 1 year ago

Cencora to Host Inaugural Product Showcase

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

Nov 6, 2024, 11:38 AM EST - 1 year ago

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Nov 6, 2024, 10:56 AM EST - 1 year ago

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

AtomicAIerts
AtomicAIerts Dec. 5 at 5:45 AM
$COR AtomicAlerts Scalp Alert Direction: SHORT Entry: $337.65 TP1: $336.95 | TP2: $336.25 | TP3: $335.55 Stop Loss: $338.25 👉 https://atomicalerts.com
0 · Reply
Iightning
Iightning Dec. 5 at 1:07 AM
1ightning® Premium Options Alert (Actionable) Ticker: $COR Contract: Dec 19 $340C Entry: 6.75 Exit: 13.20 Return: +95.57% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 7:36 PM
1ightning® Premium Options Alert (Actionable) Ticker: $COR Contract: Dec 19 $340C Entry: 6.75 Exit: 13.20 Return: +95.57% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 4:12 PM
$COR AtomicAlerts® Scalp Alert Direction: SHORT Entry: $335.73 TP1: $335.03 | TP2: $334.33 | TP3: $333.63 Stop Loss: $336.33 EMA9: 335.65 | EMA21: 335.72 RSI14: 40.22 | VWAP: 338.52 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 2:36 PM
$COR AtomicAlerts® Scalp Alert Direction: SHORT Entry: $335.45 TP1: $334.75 | TP2: $334.05 | TP3: $333.35 Stop Loss: $336.05 EMA9: 335.1 | EMA21: 334.85 RSI14: 64.78 | VWAP: 338.69 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 1:01 PM
$COR AtomicAlerts® Scalp Alert Direction: SHORT Entry: $335.28 TP1: $334.58 | TP2: $333.88 | TP3: $333.18 Stop Loss: $335.88 EMA9: 334.65 | EMA21: 334.57 RSI14: 58.63 | VWAP: 344.31 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 11:27 AM
$COR AtomicAlerts® Scalp Alert Direction: SHORT Entry: $335.28 TP1: $334.58 | TP2: $333.88 | TP3: $333.18 Stop Loss: $335.88 EMA9: 334.65 | EMA21: 334.57 RSI14: 58.63 | VWAP: 344.31 Paid Alerts: https://atomicalerts.com
0 · Reply
Iightning
Iightning Dec. 4 at 3:20 AM
1ightning® Premium Options Alert (Actionable) Ticker: $COR Contract: Dec 19 $340C Entry: 5.95 Exit: 11.36 Return: +90.89% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Arcides
Arcides Dec. 3 at 7:09 PM
$COR $MCK both had follow through down today...for now looks like ride is over.
3 · Reply
Knowledgeworthmore
Knowledgeworthmore Dec. 3 at 8:17 AM
$OTLK dont forget that yesterday he mention that, $COR was very fast to open global market for otlk for new comers cor is partner eith otlk for global market.
0 · Reply
Iightning
Iightning Dec. 3 at 8:07 AM
1ightning® Premium Options Alert (Actionable) Ticker: $COR Contract: Dec 19 $300C Entry: 51.35 Exit: 73.64 Return: +43.40% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Arcides
Arcides Dec. 2 at 10:33 PM
$COR another one like $MCK first close below 21ema on high volume since mid sept
0 · Reply
Iightning
Iightning Dec. 1 at 9:33 PM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $COR **Contract:** Dec 19 $370C **Entry:** 6.25 **Exit:** 9.81 **Return:** **+56.92% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 29 at 7:32 AM
$COR Current Stock Price: $368.99 Contracts to trade: $370 COR Dec 19 2025 Call Entry: $7.40 Exit: $13.72 ROI: 85% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Glider549
Glider549 Nov. 28 at 5:09 PM
$COR Love these medical distribution stocks! $MCK $CAH
1 · Reply
SuperGreenToday
SuperGreenToday Nov. 28 at 2:02 AM
$COR Share Price: $368.44 Contract Selected: Mar 20, 2026 $370 Calls Buy Zone: $17.76 – $21.95 Target Zone: $29.53 – $36.10 Potential Upside: 57% ROI Time to Expiration: 112 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
gogo66so
gogo66so Nov. 26 at 6:48 PM
$COR Cencora's role as a distributor of ORLYNVAH has been confirmed by Iterum Therapeutics as part of its commercial launch strategy, but Cencora itself has not issued separate, specific news related to this particular agreement. Iterum Therapeutics' Statements In its Q3 2025 earnings report and a subsequent business update on November 24, 2025, Iterum management confirmed the following: Availability via Cencora: Iterum CEO Corey Fishman stated that they have already shipped ORLYNVAH to McKesson and "will be shipping Orlynvah to Cencora shortly". Strategic Approach: Iterum views Cencora and McKesson as key distribution channels to facilitate broader physician access to ORLYNVAH beyond the specialty pharmacy network (Alto Pharmacy).
0 · Reply
Iightning
Iightning Nov. 26 at 12:17 AM
1ightning® Options Trade Alert (Actionable) | Buy $COR Dec 19 $380 Call | Enter: $4.82 Exit: $8.93 | Profit: 85.27% ROI | https://1ightning.com
0 · Reply
d_risk
d_risk Nov. 25 at 8:44 PM
$COR - Cencora Inc. Common Stock - 10K - Updated Risk Factors COR’s 2025 10-K risk factors highlight rising accounts receivable exposure to Walgreens/Boots despite lower revenue share, new risks from contract renewals, expanded operational and regulatory threats from acquisitions and global markets, heightened drug pricing and competition pressures, broader supply chain and credit risks, evolving cybersecurity and AI threats, and increased scrutiny from global tax, privacy, and anti-corruption laws. #PharmaceuticalIndustry #CybersecurityThreats #SupplyChainRisks #DrugPricingPressure #ContractRenewalRisks 🟢 Added 🟠 Removed https://d-risk.ai/COR/10-K/2025-11-25
0 · Reply
Iightning
Iightning Nov. 25 at 10:25 AM
1ightning® Options Trade Alert (Actionable) | Buy $COR Dec 19 $380 Call | Enter: $4.82 Exit: $8.93 | Profit: 85.27% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 24 at 11:21 PM
1ightning® Options Trade Alert (Actionable) | Buy $COR Dec 19 $380 Call | Enter: $4.82 Exit: $8.93 | Profit: 85.27% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 21 at 8:39 PM
1ightning® Options Trade Alert (Actionable) | Buy $COR Dec 19 $370 Call | Enter: $8.60 Exit: $15.52 | Profit: 80.45% ROI | https://1ightning.com
0 · Reply